Clinical trial
Biospecimen Biorepository for the Study of ALS, ALS-FTD and Similar Neurodegenerative Disorders
NCT05116943 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biospecimen Biorepository for the Study of ALS, ALS-FTD and Similar Neurodegenerative Disorders
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 19, 2013
- Completion date
- January 31, 2030
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.